Lombard Odier Asset Management (Switzerland) Sa Sangamo Therapeutics, Inc Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.4 Billion
Q1 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.77 - $5.07 $206,475 - $377,917	-74,540 Reduced 10.92%	607,760 $1.91 Million
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $411,922 - $616,436	-96,469 Reduced 12.39%	682,300 $3.34 Million
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.21 $268,740 - $508,803	-81,933 Reduced 9.52%	778,769 $3.22 Million
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $3.55 Million - $5.31 Million	-679,292 Reduced 44.11%	860,702 $5 Million
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $949,580 - $1.43 Million	130,258 Added 9.24%	1,539,994 $11.6 Million

Q3 2021 Nov 12, 2021	BUY	$9.01 - $12.01 $1.83 Million - $2.44 Million	202,795 Added 16.8%	1,409,736 $12.7 Million
Q2 2021 Aug 13, 2021	BUY	$10.17 - $12.64 $3.65 Million - $4.53 Million	358,512 Added 42.26%	1,206,941 $14.4 Million
Q1 2021 May 17, 2021	BUY	$10.88 - $17.05 $9.23 Million - $14.5 Million	848,429 New	848,429 $10.6 Million

Others Institutions Holding SGMO

# of Institutions

138

Shares Held

100M

Call Options Held

35.5K

Put Options Held

65.8K

Wasatch Advisors Inc Salt Lake City, UT

20.1M
Shares

$7.25 Million
0.07% of portfolio
Armistice Capital, LLC New York, NY

17M
Shares

$6.11 Million
0.15% of portfolio
Black Rock Inc. New York, NY

13.3M
Shares

$4.78 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

12.2M
Shares

$4.39 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

4.94M
Shares

$1.78 Million
0.01% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $56.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account